NK Cell-Mediated Immunologic Responses Against Myeloma by B7-1 (CD80)/IL-2 Immune Gene Therapy (2009)

First Author: Guven H.
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 9

Parent Publication: CLINICAL LYMPHOMA & MYELOMA

ISSN: 1557-9190